Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -22.46% vs -2.33% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -89.99% vs 410.25% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -35.29% vs -34.73% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -33.33% vs 125.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Tianjin Lisheng Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -22.46% vs -2.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.58% vs 7.91% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -89.99% vs 410.25% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -56.93% vs -73.43% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -35.29% vs -34.73% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -0.86% vs -57.25% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -33.33% vs 125.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






